Literature DB >> 18443246

Metabolic management of acute myocardial infarction comes to the fore and extends beyond control of hyperglycemia.

Lionel H Opie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18443246     DOI： 10.1161/CIRCULATIONAHA.108.780999

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  11 in total

Review 1.  Top 10 cardiovascular therapies and interventions for the next decade.

Authors:  Valentin Fuster
Journal:  Nat Rev Cardiol       Date:  2014-09-30       Impact factor: 32.419

2.  Differential effects of AMP-activated protein kinase in isolated rat atria subjected to simulated ischemia-reperfusion depending on the energetic substrates available.

Authors:  Romina Hermann; Victoria Evangelina Mestre Cordero; María de Las Mercedes Fernández Pazos; Federico Joaquín Reznik; Débora Elisabet Vélez; Enrique Alberto Savino; María Gabriela Marina Prendes; Alicia Varela
Journal:  Pflugers Arch       Date:  2017-10-14       Impact factor: 3.657

3.  Impaired myocardial microcirculation in the flow-glucose metabolism mismatch regions in revascularized acute myocardial infarction.

Authors:  Yoshitomo Fukuoka; Akira Nakano; Naoto Tama; Kanae Hasegawa; Hiroyuki Ikeda; Tetsuji Morishita; Kentaro Ishida; Kenichi Kaseno; Naoki Amaya; Hiroyasu Uzui; Hidehiko Okazawa; Hiroshi Tada
Journal:  J Nucl Cardiol       Date:  2016-06-14       Impact factor: 5.952

4.  Acute Hepatic Insulin Resistance Contributes to Hyperglycemia in Rats Following Myocardial Infarction.

Authors:  Jiali Wang; Baoshan Liu; Hui Han; Qiuhuan Yuan; Mengyang Xue; Feng Xu; Yuguo Chen
Journal:  Mol Med       Date:  2015-02-23       Impact factor: 6.354

Review 5.  Insulin therapy in acute coronary syndromes: an appraisal of completed and ongoing randomised trials with important clinical end points.

Authors:  Abhinav Goyal; Kara Nerenberg; Hertzel C Gerstein; Guillermo Umpierrez; Peter W F Wilson
Journal:  Diab Vasc Dis Res       Date:  2008-11       Impact factor: 3.291

6.  Very early administration of glucose-insulin-potassium by emergency medical service for acute coronary syndromes: Biological mechanisms for benefit in the IMMEDIATE Trial.

Authors:  Harry P Selker; William S Harris; Charles E Rackley; Julian B Marsh; Robin Ruthazer; Joni R Beshansky; Eric J Rashba; Inga Peter; Lionel H Opie
Journal:  Am Heart J       Date:  2016-06-02       Impact factor: 4.749

7.  Signal transducer and activator of transcription 3 is involved in the cardioprotective signalling pathway activated by insulin therapy at reperfusion.

Authors:  Britt N Fuglesteg; Naushaad Suleman; Crina Tiron; Tambuzai Kanhema; Lydia Lacerda; Thomas V Andreasen; Michael N Sack; Anne K Jonassen; Ole D Mjøs; Lionel H Opie; Sandrine Lecour
Journal:  Basic Res Cardiol       Date:  2008-05-23       Impact factor: 17.165

8.  Blood glucose control for patients with acute coronary syndromes in Qatar.

Authors:  Kyle John Wilby; Eman Elmekaty; Ibtihal Abdallah; Masa Habra; Khalid Al-Siyabi
Journal:  Saudi Pharm J       Date:  2015-03-19       Impact factor: 4.330

9.  Glucagon-like peptide-1 protects against ischemic left ventricular dysfunction during hyperglycemia in patients with coronary artery disease and type 2 diabetes mellitus.

Authors:  Liam M McCormick; Patrick M Heck; Liam S Ring; Anna C Kydd; Sophie J Clarke; Stephen P Hoole; David P Dutka
Journal:  Cardiovasc Diabetol       Date:  2015-08-08       Impact factor: 9.951

10.  Lipid, adipokine and ghrelin levels in myocardial infarction patients with insulin resistance.

Authors:  Olga Gruzdeva; Evgenya Uchasova; Ekaterina Belik; Yulia Dyleva; Ekaterina Shurygina; Olga Barbarash
Journal:  BMC Cardiovasc Disord       Date:  2014-01-16       Impact factor: 2.298
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.